JAK2V617F-dependent regulation of PRMT5 has provided an understanding of the molecular pathogenesis of myeloproliferative neoplasm; however, the regulatory mechanism for PRMT5 activity in normal physiological processes is yet to be unraveled. This evidence concerns the gene PRMT5 and myeloproliferative neoplasm.